UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000008050
Receipt number R000009479
Scientific Title Prognostic study of risk reduction among Japanese ischemic heart disease patients with coronary revascularization using quantitative analysis of gated myocardial perfusion SPECT
Date of disclosure of the study information 2012/05/31
Last modified on 2016/11/30 11:07:27

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prognostic study of risk reduction among Japanese ischemic heart disease patients with coronary revascularization using quantitative analysis of gated myocardial perfusion SPECT

Acronym

Multicenter study for assessment of usefulness of gated myocardial perfusion SPECT in patients receiving revascularization therapy (J-ACCESS4)

Scientific Title

Prognostic study of risk reduction among Japanese ischemic heart disease patients with coronary revascularization using quantitative analysis of gated myocardial perfusion SPECT

Scientific Title:Acronym

Multicenter study for assessment of usefulness of gated myocardial perfusion SPECT in patients receiving revascularization therapy (J-ACCESS4)

Region

Japan


Condition

Condition

Ischemic heart disease

Classification by specialty

Cardiology Radiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate weather revascularization therapy reduce for cardiac events risk assessed by 99mTc-Tetrofosmin gated myocardial perfusion SPECT

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Cardiac death, Sudden death, Non-cardiac death, Hospitalization of heart failure

Key secondary outcomes

Non fatal myocardial infarction,
Hospitalization for unstable angina, Stroke, Coronary or peripheral artery infarction, Receiving PCI or CABG


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1)Ischemic heart disease (IHD) patients (include suspected IHD and history of revascularization) with at least one of following symptom/findings
1)Angina or equivalent chest pain
2)Suspected IHD due to newly shortening of breath/ palpitation
3)Findings of IHD by ECG
(2)Patient>=20 years old and received written informed consent
(3)SPECT study performed indicated time period

Key exclusion criteria

(1)ACS patient within 3 months prior to registration
(2)History of old myocardial infarction with following category
1)History of higher cardiac enzyme(CK or CK-MB more than twice of normal level or elevation of Troponin)
2) Finding of new Q wave by more than adjacent 2 lead by ECG
3) Certified non viable myocardium by cardiac imaging test
(3)patients with dialysis or peritoneal dialysis
(4)valvular disease necessary to surgical therapy
(5) Also diagnosed HCM or DCM
(6) Heart failure >= NYHA3
(7)Difficult to study Gated SPECT due to arrhythmia
(8) Drug hypersensitivity with Tetrofosmin or analogous drug
(9)Unsuitable for registration by investigator

Target sample size

500


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Tsunehiko Nishimura

Organization

Kyoto Prefectural Medical University

Division name

Radiology

Zip code


Address

465 Kajii-cho, Kawaramachi-dori hirokoji agaru Kamigyo-ku, Kyoto 602-0841 JAPAN

TEL

075-741-7212

Email

nisimura@koto.kpu-m.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kenji Ichioka

Organization

Japan Cardiovascular research foundation

Division name

J-ACCESS office

Zip code


Address

1-4-1, senri-higashicho

TEL

06-6155-1003

Homepage URL

http://www.j-access.jp/j-access4.html

Email

jimu@j-access.jp


Sponsor or person

Institute

Japan Cardiovascular research foundation

Institute

Department

Personal name



Funding Source

Organization

Japan Cardiovascular research foundation

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

北海道/Hokkaido
山形県/Yamagata-ken
福島県/Fukushima-ken
茨城県/Ibaraki-ken
群馬県/Gunma-ken
埼玉県/Saitama-ken
神奈川県/Kanagawa-ken
東京都/Tokyo-to
愛知県/Aichi-ken
静岡県/Shizuoka-ken
岐阜県/Gifu-ken
長野県/Nagano-ken
京都府/Kyoto-fu
石川県/Ishikawa-ken
滋賀県/Shiga-ken
富山県/Toyama-ken
大阪府/Osaka-fu
兵庫県/Hyogo-ken
香川県/Kagawa-ken
愛媛県/Ehime-ken
岡山県/Okayama-ken
長崎県/Nagasaki-ken
福岡県/Fukuoka-ken
熊本県/Kumamoto-ken


Other administrative information

Date of disclosure of the study information

2012 Year 05 Month 31 Day


Related information

URL releasing protocol

http://www.j-access.jp/j-access4.html

Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 04 Month 09 Day

Date of IRB


Anticipated trial start date

2012 Year 06 Month 01 Day

Last follow-up date

2015 Year 12 Month 31 Day

Date of closure to data entry

2016 Year 01 Month 31 Day

Date trial data considered complete

2016 Year 05 Month 31 Day

Date analysis concluded

2016 Year 12 Month 31 Day


Other

Other related information

Nishimura T,Nakajima K,et al.,Prognostic study of risk stratification among Japanese patients with ischemic heart disease using gated myocardial perfusion SPECT:J-ACCESS study.Eur J Nucl Med Mol Imaging 35:319-328,2008
J-ACCESS study has been reported above paper including 4,031 IHD patients.
Cardiac event correlated with myocardial SPECT parameter and able to stratifying event risk quantitatively.


Management information

Registered date

2012 Year 05 Month 29 Day

Last modified on

2016 Year 11 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009479


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name